Scaling of visuospatial attention undergoes differential longitudinal change as a function of APOE genotype prior to old age: Results from the NIMH BIOCARD study

Neuropsychology

Volumn 19, Issue 6, 2005, Pages 830-840

  Greenwood, P M ^a,c   Sunderland, Trey ^b   Putnam, Karen ^b   Levy, James ^b   Parasuraman, Raja ^a,c  

^a CATHOLIC UNIVERSITY OF AMERICA   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

Author keywords

Alzheimer's; APOE; Longitudinal; Visual search

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; ASSOCIATION; ATTENTION; COGNITIVE DEFECT; FEMALE; GENE DOSAGE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; LONGITUDINAL STUDY; MALE; NEUROPROTECTION; NORMAL HUMAN; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; TASK PERFORMANCE; VISION;

AGE FACTORS; AGED; ALLELES; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; ATTENTION; BIOLOGICAL MARKERS; DEMOGRAPHY; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PHOTIC STIMULATION; PREDICTIVE VALUE OF TESTS; RISK; SPACE PERCEPTION; UNITED STATES;

EID: 29144453342     PISSN: 08944105     EISSN: None     Source Type: Journal    
DOI: 10.1037/0894-4105.19.6.830     Document Type: Article

References (75)

1. Arendt, T., Schindler, C., Bruckner, M. K., Eschrich, K., Bigl, V., Zedlick, D., et al. (1997). Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele. Journal of Neuroscience, 17, 516-529.
2. Arriagada, P. V., Marzloff, K., & Hyman, B. T. (1992). Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology, 42, 1681-1688.
3. Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., et al. (1999). Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 96, 15233-15238.
4. Bondi, M. W., Salmon, D. P., Monsch, A. U., Galasko, D., Butters, N., Klauber, M. R., et al. (1995). Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults. Neurology, 45, 2203-2206.
5. Braak, H., Braak, E., Bohl, J., & Reintjes, R. (1996). Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease. Neurosciences Letters, 210, 87-90.
6. Bretsky, P., Guralnik, J. M., Launer, L., Albert, M., & Seeman, T. E. (2003). The role of APOE-ε4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 60, 1077-1081.
7. Cohen, R. M., Small, C., Lalonde, F., Friz, J., & Sunderland, T. (2001). Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology, 57, 2223-2228.
8. Corbetta, M., Kincade, J. M., Ollinger, J. M., McAvoy, M. P., & Shulman, G. L. (2000). Voluntary orienting is dissociated from target detection in human posterior parietal cortex. Nature Neuroscience, 3, 292-297.
9. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993, August 13). Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
10. Cutrell, E. B., & Marrocco, R. T. (2002). Electrical microstimulation of primate posterior parietal cortex initiates orienting and alerting components of covert attention. Experimental Brain Research, 144, 103-113.
11. DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., et al. (2004). ApoE and clusterin cooperatively suppress Aβ levels and deposition: Evidence that ApoE regulates extracellular Aβ metabolism in vivo. Neuron, 41, 193-202.
12. Donnai, D., & Karmiloff-Smith, A. (2000). Williams syndrome: From genotype through to the cognitive phenotype. American Journal of Medicine Genetics, 97, 164-171.
13. Downing, C. J., & Pinker, S. (1985). The spatial structure of visual attention. In M. I. Posner & O. S. M. Marin (Eds.), Attention and performance XI: Mechanisms of attention (pp. 171-187). Hillsdale, NJ: Erlbaum.
14. Drory, V. E., Birnbaum, M., Korczyn, A. D., & Chapman, J. (2001). Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 190(1-2), 17-20.
15. Eriksen, C. W., & St. James, J. D. (1986). Visual attention within and around the field of focal attention: A zoom lens model. Perception & Psychophysics, 40, 225-240.
16. Eriksen, C. W., & Yeh, Y. Y. (1985). Allocation of attention in the visual field. Journal of Experimental Psychology: Human Perception and Performance, 11, 583-597.
17. Evans, D. A., Beckett, L. A., Field, T. S., Feng, L., Albert, M. S., Bennett, D. A., et al. (1997). Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons. Journal of the American Medical Association, 277, 822-824.
18. Fazekas, F., Strasser-Fuchs, S., Kollegger, H., Berger, T., Kristoferitsch, W., Schmidt, H., et al. (2001). Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis. Neurology, 57, 853-857.
19. Ferguson, S. C., Deary, I. J., Evans, J. C., Ellard, S., Hattersley, A. T., & Frier, B. M. (2003). Apolipoprotein-e influences aspects of intellectual ability in type 1 diabetes. Diabetes, 52, 145-148,
20. Feskens, E. J. M., Havekes, L. M., Kalmijn, S., Knijff, P. d., Launer, L. J., & Kromhout, D. (1994). Apolipoprotein e4 allele and cognitive decline in elderly men. British Journal of Medicine, 309, 1202-1206.
21. Flory, J. D., Manuck, S. B., Ferrell, R. E., Ryan, C. M., & Muldoon, M. F. (2000). Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. American Journal of Medical Genetics, 96, 707-711.
22. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Current Psychiatric Research, 12, 189-198.
23. Fu, S., Caggiano, D. M., Greenwood, P. M., & Parasuraman, R. (2005). Event-related potentials reveal dissociable mechanisms for orienting and focusing visuospatial attention. Cognitive Brain Research, 23, 341-353.
24. Ghebremedhin, E., Schultz, C., Braak, E., & Braak, H. (1998). High frequency of apolipoprotein E ε4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Experimental Neurology, 153, 152-155.
25. Glockner, F., Meske, V., & Ohm, T. G. (2002). Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease. Neuroscience, 114, 1103-1114.
26. Greenwood, P. M., Lambert, J. C., Sunderland, T., & Parasuraman, R. (2005). Effects of APOE genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: Results from the NIMH BIOCARD study. Neuropsychology, 19, 199-211.
27. Greenwood, P. M., & Parasuraman, R. (1996, April). Control of the focus of visuospatial attention in healthy aging. Paper presented at the Cognitive Aging Conference, Atlanta, GA.
28. Greenwood, P. M., & Parasuraman, R. (1999). Scale of attentional focus in visual search. Perception & Psychophysics, 61, 837-859.
29. Greenwood, P. M., & Parasuraman, R. (2003). Normal genetic variation, cognition, and aging. Behavioral and Cognitive Neuroscience Reviews, 2, 278-306.
30. Greenwood, P. M., & Parasuraman, R. (2004). The scaling of spatial attention in visual search and its modification in healthy aging. Perception & Psychophysics, 66, 3-22.
31. Greenwood, P. M., Parasuraman, R., & Alexander, G. E. (1997). Controlling the focus of spatial attention during visual search: Effects of advanced aging and Alzheimer disease. Neuropsychology, 11, 3-12.
32. Greenwood, P. M., Sunderland, T., Friz, J. L., & Parasuraman, R. (2000). Genetics and visual attention: Selective deficits in healthy adult carriers of the varepsilon 4 allele of the apolipoprotein E gene. Proceedings of the National Academy of Sciences, USA, 97, 11661-11666.
33. Hall, C. B., Lipton, R. B., Sliwinski, M., & Stewart, W. F. (2000). A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Statistics in Medicine, 19(11-12), 1555-1566.
34. Henderson, A. S., Easteal, S., Jorm, A. F., Mackinnon, A. J., Korten, A. E., Christensen, H., et al. (1995). Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample, Lancet, 346, 1387-1390.
35. Ho, P. I., Ashline, D., Dhitavat, S., Ortiz, D., Collins, S. C., Shea, T. B., et al. (2003). Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine. Neurobiology of Disease, 14, 32-42.
36. Hyman, B. T., Gomez-Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F., et al. (1996). Apolipoprotein E and cognitive change in an elderly population. Annals of Neurology, 40, 55-66.
37. Jonker, C., Schmand, B., Lindeboom, J., Havekes, L. M., & Launer, L. J. ( 1998). Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Archives of Neurology, 55, 1065-1069.
38. Killiany, R. J., Hyman, B. T., Gomez-Isla, T., Moss, M. B., Kikinis, R., Jolesz, F., et al. (2002). MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology, 58, 1188-1196.
39. Laird, N., & Ware, J. (1982). Random effects models for longitudinal data. Biometrics, 38, 963-974.
40. Lauderback, C. M., Kanski, J., Hackett, J. M., Maeda, N., Kindy, M. S., & Butterfield, D. A. (2002). Apolipoprotein E modulates Alzheimer's Aβ(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Research, 924, 90-97.
41. Levy, J. A., Bergeson, J., Putnam, K., Rosen, V., Cohen, R., Lalonde, F., et al. (2004). Context-specific memory and apolipoprotein E (ApoE) epsilon 4: Cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease. Journal of the International Neuropsychological Society, 10, 362-370.
42. Levy, J. A., Parasuraman, R., Greenwood, P. M., Dukoff, R., & Sunderland, T. (2000). Acetylcholine affects the spatial scale of attention: Evidence from Alzheimer's disease. Neuropsychology, 14, 288-298.
43. Lichtman, S. W., Seliger, G., Tycko, B., & Marder, K. (2000). Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology, 55, 1536-1539.
44. Linn, R. T., Wolf, P. A., Bachman, D. L., Knoefel, J. E., Cobb, J. L., Belanger, A. J., et al. (1995). The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Archives of Neurology, 52, 485-490.
45. Lippa, C. F., Smith, T. W., Saunders, A. M., Hulette, C., Pulaski-Salo, D., & Roses, A. D. (1997). Apolipoprotein E-epsilon 2 and Alzheimer's disease: Genotype influences pathologic phenotype. Neurology, 48, 515-519.
46. Luo, Y. J., Greenwood, P. M., & Parasuraman, R. (2001). Dynamics of the spatial scale of visual attention revealed by brain event-related potentials. Cognitive Brain Research, 12, 371-381.
47. Mattis, S. (1976). Mental status evaluation for organic mental syndrome in the elderly patient. In L. Bellak & T. B. Karasu (Eds.), Geriatric psychiatry (pp. 77-121). New York: Grune & Stratton.
48. Mattson, M. P. (2003). Will caloric restriction and folate protect against AD and PD? Neurology, 60, 690-695.
49. Mauch, D. H., Nagler, K., Schumacher, S., Goritz, C., Muller, E. C., Otto, A., et al. (2001, November 9). CNS synaptogenesis promoted by glia-derived cholesterol. Science, 294, 1354-1357.
50. Mayeux, R., Small, S. A., Tang, M., Tycko, B., & Stern, Y. (2001). Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E. Neurobiology of Aging, 22, 683-689.
51. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 934-939.
52. Meyer, M. R., Tschanz, J. T., Norton, M. C., Welsh-Bohmer, K. A., Steffens, D. C., Wyse, B. W., et al. (1998). APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease. Nature Genetics, 19, 321-322.
53. Naslund, J., Schierhorn, A., Hellman, U., Lannfelt, L., Roses, A. D., Tjernberg, L. O., et al. (1994). Relative abundance of Alzheimer Aβamyloid peptide variants in Alzheimer disease and normal aging. Proceedings of the National Academy of Sciences, USA, 91, 8378-8382.
54. Nobre, A. C., Sebestyen, G. N., Gitelman, D. R., Mesulam, M. M., Frackowiak, R. S., & Frith, C. D. (1997). Functional localization of the system for visuospatial attention using positron emission tomography. Brain, 120, 515-533.
55. Panza, F., Solfrizzi, V., Torres, F., Mastroianni, F., Colacicco, A. M., Basile, A. M., et al. (2000). Apolipoprotein E in Southern Italy: Protective effect of ε2 allele in early- and late-onset sporadic Alzheimer's disease. Neuroscience Leiters, 292, 79-82.
56. Parasuraman, R., Greenwood, P. M., & Alexander, G. E. (1995). Selective impairment of spatial attention during visual search in Alzheimer's disease. NeuroReport, 6, 1861-1864.
57. Plassman, B. L., Welsh-Bohmer, K. A., Bigler, E. D., Johnson, S. C., Anderson, C. V., Helms, M. J., et al. (1997). Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology, 48, 985-989.
58. Poirier, J. (1994). Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends in Neurosciences, 17, 525-530.
59. Posner, M. I. (1980). Orienting of attention. Quarterly Journal of Experimental Psychology, 32, 3-25.
60. Potter, H., Wefes, I. M., & Nilsson, L. N. (2001). The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation. Neurobiology of Aging, 22, 923-930.
61. Rebeck, G. W., Alonzo, N. C., Berezovska, O., Harr, S. D., Knowles, R. B., Growdon, J. H., et al. (1998). Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes. Experimental Neurology, 149, 175-182.
62. Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001). Declining brain activity in cognitively normal apolipoprotein E ε4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 98, 3334-3339.
63. Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., et al. (1996). Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. New England Journal of Medicine, 334, 752-758.
64. Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., et al. (2004). Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proceedings of the National Academy of Sciences, USA, 101, 284-289.
65. Sliwinski, M., Hofer, S. M., Hall, C., Buschke, H., & Lipton, R. B. (2003). Modeling memory decline in older adults: The importance of preclinical dementia, attrition, and chronological age. Psychology and Aging, 18, 658-671.
66. Sliwinski, M., Lipton, R. B., Buschke, H., & Stewart, W. (1996). The effects of preclinical dementia on estimates of normal cognitive functioning in aging. Journal of Gerontology: Psychological Sciences, 51B, P217-P225.
67. Small, B. J., Fratiglioni, L., Viitanen, M., Winblad, B., & Backman, L. (2000). The course of cognitive impairment in preclinical Alzheimer disease: Three- and 6-year follow-up of a population-based sample. Archives of Neurology, 57, 839-844.
68. Smith, G. E., Bohac, D. L., Waring, S. C., Kokmen, E., Tangalos, E. G., Ivnik, R. J., et al. (1998). Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology, 50, 355-362.
69. Talbot, C., Lendon, C., Craddock, N., Shears, S., Morris, J. C., & Goate, A. (1994, June 4). Protection against Alzheimer's disease with apoE ε2. Lancet, 343, 1432-1433.
70. Teter, B., Xu, P. T., Gilbert, J. R., Roses, A. D., Galasko, D., & Cole, G. M. (2002). Defective neuronal sprouting by human apolipoprotein ε4 is a gain-of-negative function. Journal of Neuroscience Research, 68, 331-336.
71. Wechsler, D. (1981). Wechsler Adult Intelligence Scale-revised. New York: Psychological Corporation.
72. West, H. L., Rebeck, W., & Hyman, B. T. (1994). Frequency of apolipoprotein E ε2 allele is diminished in sporadic Alzheimer's disease. Neuroscience Letters, 175, 46-48.
73. White, F., Nicoll, J. A., Roses, A. D., & Horsburgh, K. (2001). Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiology of Disease, 8, 611-625.
74. Wilson, R. S., Bienias, J. L., Berry-Kravis, E., Evans, D. A., & Bennett, D. A. (2002). The apolipoprotein E ε2 allele and decline in episodic memory. Journal of Neurology, Neurosurgery & Psychiatry, 73, 672-677.
75. Wilson, R. S., Schneider, J. A., Barnes, L. L., Beckett, L. A., Aggarwal, N. T., Cochran, E. J., et al. (2002). The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Archives of Neurology, 59, 1154-1160.